TENOFOVIR VERSUS ENTECAVIR FOR HEPATOCELLULAR CARCINOMA PREVENTION IN AN INTERNATIONAL CONSORTIUM OF CHRONIC HEPATITIS B

被引：0

作者：

Hsu, Yao-Chun ^{[1
]}

Wong, Grace Lai-Hung ^{[2
,3
]}

Chen, Chien Hung ^{[4
]}

Peng, Cheng-Yuan ^{[5
]}

Yeh, Ming-Lun ^{[6
]}

Cheung, Ka-Shing ^{[7
]}

Toyoda, Hidenori ^{[8
]}

Huang, Chung-Feng ^{[9
]}

Trinh, Huy N. ^{[10
]}

Xie, Qing ^{[11
]}

Enomoto, Masaru ^{[12
]}

Liu, Li ^{[13
]}

Yasuda, Satoshi ^{[8
]}

Tanaka, Yasuhito ^{[14
,15
]}

Kozuka, Ritsuzo ^{[12
]}

Tsai, Pei-Chien ^{[6
]}

Huang, Yen-Tsung ^{[16
]}

Wong, Christopher ^{[17
]}

Huang, Rui ^{[18
]}

Jang, Tyng-Yuan ^{[19
]}

Hoang, Joseph ^{[20
]}

Yang, Hwai-I ^{[21
]}

Li, Jiayi ^{[22
]}

Lee, Dong Hyun ^{[23
]}

Takahashi, Hirokazu ^{[24
]}

Zhang, Jianqing ^{[25
]}

Ogawa, Eiichi ^{[26
]}

Zhao, Changqing ^{[27
]}

Liu, Chenghai ^{[28
]}

Furusyo, Norihiro ^{[26
]}

Eguchi, Yuichiro ^{[29
]}

Wong, Clifford ^{[17
]}

Wu, Chao ^{[18
]}

Kumada, Takashi ^{[30
]}

Yuen, Man-Fung ^{[31
]}

Yu, Ming-Lung ^{[6
]}

Nguyen, Mindie H. ^{[20
]}

机构：

[1] I Shou Univ, Kaohsiung, Taiwan

[2] Chinese Univ Hong Kong, Inst Digest Dis, Dept Med & Therapeut, Hong Kong, Peoples R China

[3] Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Peoples R China

[4] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan

[5] China Med Univ, Sch Med, Taichung, Taiwan

[6] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan

[7] Queen Mary Hosp, Med, Hong Kong, Peoples R China

[8] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Gifu, Japan

[9] Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan

[10] San Jose Gastroenterol, San Jose, CA USA

[11] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Infect Dis, Shanghai, Peoples R China

[12] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka, Japan

[13] Third Hosp Kumming City, Kunming, Yunnan, Peoples R China

[14] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan

[15] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan

[16] Acad Sinica, Taipei, Taiwan

[17] Wong Clin, Singapore, Singapore

[18] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Infect Dis,Affiliated Hosp, Nanjing, Jiangsu, Peoples R China

[19] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan

[20] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA

[21] Acad Sinica, Genom Res Ctr, Taipei, Taiwan

[22] Palo Alto Med Fdn, Mt View Div, Palo Alto, CA USA

[23] Good Gang An Hosp, Busan, South Korea

[24] Saga Univ, Fac Med, Div Endocrinol & Metab, Saga, Japan

[25] Chinese Hosp, Beijing, Peoples R China

[26] Kyushu Univ Hosp, Dept Gen Internal Med, Fukuoka, Fukuoka, Japan

[27] Shuguang Hosp, Inst Liver Dis, Shanghai, Peoples R China

[28] Shanghai Univ TCM, Shuguang Hosp, Inst Liver Dis, Shanghai, Peoples R China

[29] Saga Med Sch, Fac Med, Dept Internal Med, Saga, Japan

[30] Ogaki Municipal Hosp, Ogaki, Gifu, Japan

[31] Univ Hong Kong, Queen Mary Hosp, Hong Kong, Peoples R China

来源：

HEPATOLOGY | 2019年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

459

引用

页码：290A / 291A

页数：2

共 50 条

[41] Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
Hye Won Lee
Young Youn Cho
Hyein Lee
Jae Seung Lee
Seung Up Kim
Jun Yong Park
Do Young Kim
Sang Hoon Ahn
Beom Kyung Kim
Soo Young Park
[J]. Hepatology International, 2021, 15 : 1083 - 1092
[42] Remaining hepatocellular carcinoma risk in chronic hepatitis B patients receiving entecavir/tenofovir in South Korea
Yu, Jung Hwan
Jin, Young-Joo
Lee, Jin-Woo
Lee, Don-Haeng
[J]. HEPATOLOGY RESEARCH, 2018, 48 (11) : 862 - 871
[43] Hepatitis B: Tenofovir is superior than Entecavir for treating Patients with Hepatocellular Carcinoma
Lorenz, Judith
[J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (08):
[44] Chronic Hepatitis B: Tenofovir and Entecavir compared
Kessing, Richard
[J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (09):
[45] Comparison of tenofovir versus entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta-analysis
Gu, Lihu
Yao, Qigu
Shen, Zefeng
He, Ying
Ng, Derry Minyao
Yang, Tong
Chen, Bangsheng
Chen, Ping
Mao, Feiyan
Yu, Qili
[J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (09) : 1467 - 1476
[46] Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis
Dave, Shravan
Park, Sooyoung
Murad, M. Hassan
Barnard, Abbey
Prokop, Larry
Adams, Leon A.
Singh, Siddharth
Loomba, Rohit
[J]. HEPATOLOGY, 2021, 73 (01) : 68 - 78
[47] Entecavir versus tenofovir disoproxil fumarate on the reduction of incidence of hepatocellular carcinoma in patients with chronic hepatitis B-related liver cirrhosis
Lin, Yu-Hung
Lai, Huang-Lun
Wang, Chun-Hsiang
Chang, Kuo-Kuan
Mo, Lein-Ray
Lin, Ruey-Chang
[J]. ADVANCES IN DIGESTIVE MEDICINE, 2024, 11 (01) : 16 - 23
[48] Entecavir versus tenofovir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy
Kao, Wei-Yu
Tan, Elise Chia-Hui
Lee, Hsin-Lun
Huang, Yi-Hsiang
Huo, Teh-Ia
Chang, Chun-Chao
Chiou, Jeng-Fong
Hou, Ming-Chih
Wu, Jaw-Ching
Su, Chien-Wei
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (11) : 1299 - 1312
[49] Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection
Choi, Jonggi
Jo, Chanyoung
Lim, Young-Suk
[J]. HEPATOLOGY, 2021, 73 (02) : 661 - 673
[50] Hepatocellular Carcinoma Incidence In Chronic Hepatitis B Patients Under Long-Term Treatment With Entecavir And Tenofovir
Cardoso, Helder
Gaspar, Rui
Silva, Marco
Vale, Ana
Macedo, Guilherme
[J]. HEPATOLOGY, 2015, 62 : 961A - 961A

← 1 2 3 4 5 →